Interspecies scaling: Predicting volumes, mean residence time and elimination half-life. Some suggestions

被引:42
作者
Mahmood, I [1 ]
机构
[1] US FDA, Off Clin Pharmacol & Biopharmaceut, Div Pharmaceut Evaluat 1, Woodmont Off Ctr 2, Rockville, MD 20852 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb06190.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extrapolation of animal data to assess pharmacokinetic parameters in man is an important tool in drug development. Clearance, volume of distribution and elimination half-life are the three most frequently extrapolated pharmacokinetic parameters. Extensive work has been done to improve the predictive performance of allometric scaling for clearance. In general there is good correlation between body weight and volume, hence volume in man can be predicted with reasonable accuracy from animal data. Besides the volume of distribution in the central compartment (V-c), two other volume terms, the volume of distribution by area (V-beta) and the volume of distribution at steady state (Vd(ss)), are also extrapolated from animals to man. This report compares the predictive performance of allometric scaling for V-c, V-beta and Vd(ss) in man from animal data. The relationship between elimination half-life (t1/2) and body weight across species results in poor correlation, most probably because of the hybrid nature of this parameter. To predict half-life in man from animal data, an indirect method (CL=VK, where CL=clearance, V is volume and K is elimination rate constant) has been proposed. This report proposes another indirect method which uses the mean residence time (MRT). After establishing that MRT can be predicted across species, it was used to predict half-life using the equation MRT = 1.44 x t1/2. The results of the study indicate that V, is predicted more accurately than Vp and Vdss in man. It should be emphasized that for first-time dosing in man, V,is a more important pharmacokinetic parameter than Vp or Vdss. Furthermore, MRT can be predicted reasonably well for man and can be used for prediction of half-life.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 36 条
[12]  
ELSAYED MA, 1978, ARCH INT PHARMACOD T, V234, P180
[13]   INTERSPECIES SCALING OF CIMETIDINE THEOPHYLLINE PHARMACOKINETIC INTERACTION - INTERSPECIES SCALING IN PHARMACOKINETIC INTERACTIONS [J].
GASCON, AR ;
CALVO, B ;
HERNANDEZ, RM ;
DOMINGUEZGIL, A ;
PEDRAZ, JL .
PHARMACEUTICAL RESEARCH, 1994, 11 (07) :945-950
[14]   CYCLOSPORINE METABOLISM AND PHARMACOKINETICS FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION IN THE DOG [J].
GRIDELLI, B ;
SCANLON, L ;
PELLICCI, R ;
LAPOINTE, R ;
DEWOLF, A ;
SELTMAN, H ;
DIVEN, W ;
SHAW, B ;
STARZL, T ;
SANGHVI, A .
TRANSPLANTATION, 1986, 41 (03) :388-391
[15]  
HINDERLING PH, 1993, DRUG METAB DISPOS, V21, P662
[16]  
HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
[17]   Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species [J].
Hutchaleelaha, A ;
Chow, HH ;
Mayersohn, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (02) :178-183
[18]   INTERSPECIES SCALING OF INTERFERON DISPOSITION AND COMPARISON OF ALLOMETRIC SCALING WITH CONCENTRATION-TIME TRANSFORMATIONS [J].
LAVE, T ;
LEVETTRAFIT, B ;
SCHMITTHOFFMANN, AH ;
MORGENROTH, B ;
RICHTER, W ;
CHOU, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (11) :1285-1290
[19]   Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs [J].
Lave, T ;
Dupin, S ;
Schmitt, C ;
Chou, RC ;
Jaeck, D ;
Coassolo, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (05) :584-590
[20]   Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor [J].
Lave, T ;
Saner, A ;
Coassolo, P ;
Brandt, R ;
SchmittHoffmann, AH ;
Chou, RC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (06) :573-577